Resistance training and cardiometabolic risk in women with metabolically healthy and unhealthy obesity

Appl Physiol Nutr Metab. 2024 Aug 1;49(8):1068-1082. doi: 10.1139/apnm-2023-0279. Epub 2024 Apr 22.

Abstract

Despite some reported benefits, there is a low quality of evidence for resistance training (RT) improving metabolic health of individuals with overweight or obesity. We evaluated the impact of RT on body composition, cardiorespiratory fitness (CRF) and physical performance, lipid-lipoprotein profile, inflammation, and glucose-insulin homeostasis in 51 postmenopausal women versus 29 controls matched for age, obesity, and physical activity. Exercised women were further subdivided for comparison of RT effects into those presenting metabolically healthy obesity (MHO) and those with metabolically unhealthy obesity (MUHO) classified according to Karelis and Rabasa-Lhoret or an approach based on adipose tissue secretory dysfunction using the plasma adiponectin(A)/leptin (L) ratio. Participants followed a 4-month weekly RT program targeting major muscle groups (3 × 10 repetitions at 80% one repetition maximum (1-RM)). Percent fat marginally decreased and lean body mass increased (0.01 < p < 0.05) while CRF and muscular strength improved in all women, after RT (effect size (ES): 0.11-1.21 (trivial to large effects), p ˂ 0.01). Fasting plasma triacylglycerol and high-density lipoprotein-cholesterol levels slightly increased and decreased, respectively, in participants with MHO using the A/L ratio approach (ES: -0.47 to 1.07 (small to large effects), p ˂ 0.05). Circulating interleukin-6 soluble receptor decreased in both groups and soluble tumor necrosis factor receptor-1/soluble tumor necrosis factor receptor-2 in women with MUHO only, irrespective of definition (ES: -0.42 to -0.84 (small to large effects), p ˂ 0.05). Glucose-insulin homeostasis was unchanged regardless of group or definition. RT improved physical performance and body composition but had a lesser impact on cardiometabolic risk in women with obesity, irrespective of their metabolic phenotype.

Keywords: adipokines; exercise; glucose–insulin homeostasis; physical performance; postmenopausal women; secretory adiposopathy.

MeSH terms

  • Adiponectin / blood
  • Aged
  • Body Composition*
  • Cardiometabolic Risk Factors*
  • Cardiorespiratory Fitness*
  • Cardiovascular Diseases / prevention & control
  • Case-Control Studies
  • Female
  • Humans
  • Insulin Resistance
  • Leptin / blood
  • Middle Aged
  • Muscle Strength
  • Obesity / therapy
  • Obesity, Metabolically Benign / blood
  • Postmenopause
  • Resistance Training*

Substances

  • Adiponectin
  • Leptin